Aduro BioTech, Inc. (ADRO) Slides on Pancreatic Cancer Drug Setback
November 25, 2015 at 00:09 AM EST
Shares of Berkeley, California, based Aduro BioTech, Inc. (ADRO) fell on Tuesday, against the backdrop of a slightly higher day in stocks overall. Aduro stock was down 16.07%, falling $5.18 per share, to close at $27.05, on volume of 3,387,815 shares. The company's very promising new pancreatic cancer drug was dealt a setback when one ... READ MORE Read the rest of Aduro BioTech, Inc. (ADRO) Slides on Pancreatic Cancer Drug Setback at InvestorGuide.com .
